Skip to main content
SpringerLink
Log in
Book cover

Nutrition Therapy for Urolithiasis pp 99–113Cite as

Nutrition Therapy for Specific Lithogenic Risk Factors: High Urine Calcium, High Urine Oxalate

  • Chapter
  • First Online:

Abstract

The most common component of kidney stones is calcium – a major constituent of over 75% of urinary calculi [1]. Hypercalciuria, found in 10–15% of the general population and 35–65% of stone-forming population, is the most common metabolic abnormality found in these patients [2–4].

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Wilson DM. Clinical and laboratory approaches for evaluation of nephrolithiasis. J Urol. 1989;141:770–4.

    Article  CAS  PubMed  Google Scholar 

  2. Robertson WG, Morgan DB. The distribution of urinary calcium excretions in normal persons and stone-formers. Clin Chim Acta. 1972;37:503–8.

    Article  CAS  PubMed  Google Scholar 

  3. Coe FL, Kavalach AG. Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis. N Engl J Med. 1974;291:1344–50.

    Article  CAS  PubMed  Google Scholar 

  4. Coe FL, Parks JH, Asplin JR. The pathogenesis and treatment of kidney stones. N Engl J Med. 1992;327:1141–52.

    Article  CAS  PubMed  Google Scholar 

  5. Menon M, Krishnan CS. Evaluation and medical management of the patient with calcium stone disease. Urol Clin North Am. 1983;10:595–615.

    CAS  PubMed  Google Scholar 

  6. Parks JH, Coe FL. Urine citrate and calcium in calcium nephrolithiasis. Adv Exp Med Biol. 1986;208:445–9.

    Article  CAS  PubMed  Google Scholar 

  7. Pak CY, Oata M, Lawrence EC, et al. The hypercalciurias. Causes, parathyroid functions, and diagnostic criteria. J Clin Invest. 1974;54:387–400.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Robertson WG, Peacock M, Heyburn PJ, et al. Should recurrent calcium oxalate stone formers become vegetarians? Br J Urol. 1979;51:427–31.

    Article  CAS  PubMed  Google Scholar 

  9. Robertson WG, Peacock M, Marshall DH. Prevalence of urinary stone disease in vegetarians. Eur Urol. 1982;8:334–9.

    Article  CAS  PubMed  Google Scholar 

  10. Wasserstein AG, Stolley PD, Soper KA, et al. Case-control study of risk factors for idiopathic calcium nephrolithiasis. Miner Electrolyte Metab. 1987;13:85–95.

    CAS  PubMed  Google Scholar 

  11. Meschi T, Maggiore U, Fiaccadori E, et al. The effect of fruits and vegetables on urinary stone risk factors. Kidney Int. 2004;66:2402–10.

    Article  CAS  PubMed  Google Scholar 

  12. Borghi L, Schianchi T, Meschi T, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002;346:77–84.

    Article  CAS  PubMed  Google Scholar 

  13. Robertson WG, Heyburn PJ, Peacock M, Hanes FA, Swaminathan R. The effect of high animal protein intake on the risk of calcium stone-formation in the urinary tract. Clin Sci (Lond). 1979;57(3):285–8.

    Article  CAS  Google Scholar 

  14. Tracy CR, Best S, Bagrodia A, Poindexter JR, Adams-Huet B, et al. Animal protein and the risk of kidney stones: a comparative metabolic study of animal protein sources. J Urol. 2014;192(1):137–41.

    Article  CAS  PubMed  Google Scholar 

  15. Kerstetter JE, O’Brien KO, Insogna KL. Low protein intake: the impact on calcium and bone homeostasis in humans. J Nutr. 2003;133(3):855S–61S.

    CAS  PubMed  Google Scholar 

  16. Robertson WG, Hughes H. Importance of mild hyperoxaluria in the pathogenesis of urolithiasis – new evidence from studies in the Arabian peninsula. Scanning Microsc. 1993;7(1):391–401.

    CAS  PubMed  Google Scholar 

  17. Robertson WG. Stone formation in the Middle Eastern Gulf States: a review. Arab J Urol. 2012;10(3):265–72.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Barkworth SA, Louis S, Walker VR. Stone type and urine composition in the Middle East with particular reference to Saudi Arabia. New York: Urolithiasis Plenum Press. p. 715.

    Google Scholar 

  19. Reddy ST, Wang CY, Sakhaee K, Brinkley L, Pak CY. Effect of low-carbohydrate high-protein diets on acid-base balance, stone-forming propensity, and calcium metabolism. Am J Kidney Dis. 2002;40(2):265–74.

    Article  CAS  PubMed  Google Scholar 

  20. Breslau NA, Brinkley L, Hill KD, Pak CY. Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism. J Clin Endocrinol Metab. 1988;66(1):140–6.

    Article  CAS  PubMed  Google Scholar 

  21. Ruml LA, Pearle MS, Pak CY. Medical therapy, calcium oxalate urolithiasis. Urol Clin North Am. 1997;24:117–33.

    Article  CAS  PubMed  Google Scholar 

  22. Pearle MS, Goldfarb DS, Assimos DG, et al. Medical management of kidney stones: AUA guideline. J Urol. 2014;192:316–24.

    Article  PubMed  Google Scholar 

  23. Massey LK, Whiting SJ. Dietary salt, urinary calcium, and kidney stone risk. Nutr Rev. 1995;53(5):131–9.

    Article  CAS  PubMed  Google Scholar 

  24. Penniston KL, Wojciechowski KF, Nakada SY. The salt shaker provides less than 15% of total sodium intake in stone formers: food strategies to reduce sodium intake are needed. J Urol. 185:e861.

    Google Scholar 

  25. Sakhaee K, Harvey JA, Padalino PK, Whitson P, Pak CY. The potential role of salt abuse on the risk for kidney stone formation. J Urol. 1993;150(2 Pt 1):310–2.

    Article  CAS  PubMed  Google Scholar 

  26. Penniston KL, Nakada SY. Diet and alternative therapies in the management of stone disease. Urol Clin North Am. 2013;40:31–46.

    Article  PubMed  Google Scholar 

  27. Bataille P, Pruna A, Gregoire I, et al. Critical role of oxalate restriction in association with calcium restriction to decrease the probability of being a stone former: insufficient effect in idiopathic hypercalciuria. Proc Eur Dial Transplant Assoc. 1983;20:401–6.

    CAS  PubMed  Google Scholar 

  28. Trinchieri A, Nespoli R, Ostini F, et al. A study of dietary calcium and other nutrients in idiopathic renal calcium stone formers with low bone mineral content. J Urol. 1998;159:654–7.

    Article  CAS  PubMed  Google Scholar 

  29. Coe FL, Parks JH, Favus MJ. Diet and calcium: the end of an era? Ann Intern Med. 1997;126:553–5.

    Article  CAS  PubMed  Google Scholar 

  30. Hess B. Low calcium diet in hypercalciuric calcium nephrolithiasis: first do no harm. Scanning Microsc. 1996;10(2):547–54.

    CAS  PubMed  Google Scholar 

  31. Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med. 2006;354(7):669–83.

    Article  CAS  PubMed  Google Scholar 

  32. Domrongkitchaiporn S, Ongphiphadhanakul B, Stitchantrakul W, et al. Risk of calcium oxalate nephrolithiasis in postmenopausal women supplemented with calcium or combined calcium and estrogen. Maturitas. 2002;41:149–56.

    Article  CAS  PubMed  Google Scholar 

  33. Sakhaee K, Poindexter JR, Griffith CS, et al. Stone forming risk of calcium citrate supplementation in healthy postmenopausal women. J Urol. 2004;172:958–61.

    Article  CAS  PubMed  Google Scholar 

  34. Domrongkitchaiporn S, Sopassathit W, Stitchantrakul W, et al. Schedule of taking calcium supplement and the risk of nephrolithiasis. Kidney Int. 2004;65:1835–41.

    Article  CAS  PubMed  Google Scholar 

  35. Remer T, Manz F. Potential renal acid load of foods and its influence on urine pH. J Am Diet Assoc. 1995;95:791–7.

    Article  CAS  PubMed  Google Scholar 

  36. Jahnen A, Heynck H, Gertz B, et al. Dietary fibre: the effectiveness of a high bran intake in reducing renal calcium excretion. Urol Res. 1992;20:3–6.

    Article  CAS  PubMed  Google Scholar 

  37. Garg A, Bonanome A, Grundy SM, et al. Effects of dietary carbohydrates on metabolism of calcium and other minerals in normal subjects and patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1990;70:1007–13.

    Article  CAS  PubMed  Google Scholar 

  38. Weaver CM, Rothwell AP, Wood KV. Measuring calcium absorption and utilization in humans. Curr Opin Clin Nutr Metab Care. 2006;9:568–74.

    Article  CAS  PubMed  Google Scholar 

  39. Iguchi M, Umekawa T, Takamura C, et al. Glucose metabolism in renal stone patients. Urol Int. 1993;51:185–90.

    Article  CAS  PubMed  Google Scholar 

  40. Ryall RL. Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation. World J Urol. 1997;15(3):155–64.

    Article  CAS  PubMed  Google Scholar 

  41. Nicar MJ, Hill K, Pak CY. Inhibition by citrate of spontaneous precipitation of calcium oxalate in vitro. J Bone Miner Res. 1987;2:215–20.

    Article  CAS  PubMed  Google Scholar 

  42. Meschi T, Maggiore U, Fiaccadori E, Schianchi T, et al. The effect of fruits and vegetables on urinary stone risk factors. Kidney Int. 2004;66(6):2402–10.

    Article  CAS  PubMed  Google Scholar 

  43. Adler S, Fraley DS. Potassium and intracellular pH. Kidney Int. 1977;11(6):433–42.

    Article  CAS  PubMed  Google Scholar 

  44. Pearle MS, Lotan Y. Urinary lithiasis: etiology, epidemiology, and pathogenesis. In: Campbell-Walsh Urology 10th Edition. Elsevier Saunders, Philidelphia, PA. 2012. p. 1257–86.

    Google Scholar 

  45. Leumann E, Hoppe B. What is new in primary hyperoxaluria? Nephrol Dial Transplant. 1999;4:2556–8.

    Article  Google Scholar 

  46. Worcester EM. Stones from bowel disease. Endocrinol Metab Clin N Am. 2002;31:979–99.

    Article  CAS  Google Scholar 

  47. Rudman D, Dedonis JL, Fountain MT, et al. Hypocitraturia in patients with gastrointestinal malabsorption. N Engl J Med. 1980;303:657–61.

    Article  CAS  PubMed  Google Scholar 

  48. Troxel SA, Sidhu H, Kaul P, et al. Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate. J Endourol. 2003;17:173–6.

    Article  PubMed  Google Scholar 

  49. Sidhu H, Schmidt ME, Cornelius JG, et al. Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy. J Am Soc Nephrol. 1999;10(Suppl 1):S334–40.

    CAS  PubMed  Google Scholar 

  50. Penniston KL, Wojciechowski KF, Nakada SY. Dietary oxalate: what’s important and what isn’t for patients with calcium oxalate stones. J Urol. 185:e824–5.

    Google Scholar 

  51. Massey LK. Food oxalate: factors affecting measurement, biological variation, and bioavailability. J Am Diet Assoc. 2007;107(7):1191–4.

    Article  PubMed  Google Scholar 

  52. Taylor EN, Fung TT, Curhan GC. DASH-style diet associates with reduced risk for kidney stones. J Am Soc Nephrol. 2009;20(10):2253–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Robertson WG, Peacock M, Heyburn PJ, Hanes FA. Should recurrent calcium oxalate stone formers become vegetarians? Br J Urol. 1979;51(6):427–31.

    Article  CAS  PubMed  Google Scholar 

  54. Liebman M, Costa G. Effects of calcium and magnesium on urinary oxalate excretion after oxalate loads. J Urol. 2000;163(5):1565–9.

    Article  CAS  PubMed  Google Scholar 

  55. Ettinger B, Citron JT, Livermore B, Dolman LI. Chlorthalidone reduces calcium oxalate calculus occurrence but magnesium hydroxide does not. J Urol. 1988;139:679–84.

    Article  CAS  PubMed  Google Scholar 

  56. Traxer O, Huet B, Poindexter J, Pak CY, Pearle MS. Effect of ascorbic acid consumption on urinary stone risk factors. J Urol. 2003;170(2 Pt 1):397–401.

    Article  CAS  PubMed  Google Scholar 

  57. Tang M, Larson-Meyer DE, Liebman M. Effect of cinnamon and turmeric on urinary oxalate excretion, plasma lipids, and plasma glucose in healthy subjects. Am J Clin Nutr. 2008;87:1262–7.

    CAS  PubMed  Google Scholar 

  58. Terris MK, Issa MM, Tacker JR. Dietary supplementation with cranberry concentrate tablets may increase the risk of nephrolithiasis. Urology. 2001;57:26–9.

    Article  CAS  PubMed  Google Scholar 

  59. Ortiz-Alvarado O, Miyaoka R, Kriedberg C, et al. Pyridoxine and dietary counseling for the management of idiopathic hyperoxaluria in stone-forming patients. Urology. 2011;77:1054–8.

    Article  PubMed  Google Scholar 

  60. Massey LK, Sutton RA. Modification of dietary oxalate and calcium reduces urinary oxalate in hyperoxaluric patients with kidney stones. J Am Diet Assoc. 1993;93:1305–7.

    Article  CAS  PubMed  Google Scholar 

  61. Yadav S, Gite S, Nilegaonkar S, et al. Effect of supplementation of micronutrients and phytochemicals to fructooligosaccharides on growth response of probiotics and E. coli. Biofactors. 37:58–64.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Baylor Scott and White Healthcare, Texas A&M College of Medicine, Temple, TX, USA

    Marawan M. El Tayeb MD, MSc

  2. Department of Hematology/Oncology, Indiana University, Indianapolis, IN, USA

    Samar A. Ibrahim MD

Authors
  1. Marawan M. El Tayeb MD, MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Samar A. Ibrahim MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marawan M. El Tayeb MD, MSc .

Editor information

Editors and Affiliations

  1. Department of Surgery, Division of Urology, Texas A&M HSC College of Medicine, Scott & White Healthcare, Temple, Texas, USA

    Patrick Lowry

  2. Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA

    Kristina L. Penniston

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

El Tayeb, M.M., Ibrahim, S.A. (2018). Nutrition Therapy for Specific Lithogenic Risk Factors: High Urine Calcium, High Urine Oxalate. In: Lowry, P., Penniston, K. (eds) Nutrition Therapy for Urolithiasis. Springer, Cham. https://doi.org/10.1007/978-3-319-16414-4_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-16414-4_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-16413-7

  • Online ISBN: 978-3-319-16414-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation